Page last updated: 2024-08-18

isomethyleugenol and Tuberous Sclerosis

isomethyleugenol has been researched along with Tuberous Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Douglas-Jones, A; Jiang, WG; Lee-Jones, L; Mansel, RE; Martin, TA; Mokbel, K; Sampson, J; Watkins, G1
Green, AJ; Sepp, T; Yates, JR1

Other Studies

2 other study(ies) available for isomethyleugenol and Tuberous Sclerosis

ArticleYear
Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:11

    Topics: Breast Neoplasms; Cell Line, Tumor; Female; Humans; Immunohistochemistry; Methylation; Promoter Regions, Genetic; Recurrence; Repressor Proteins; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins

2005
Clonality of tuberous sclerosis harmatomas shown by non-random X-chromosome inactivation.
    Human genetics, 1996, Volume: 97, Issue:2

    Topics: Angiomyolipoma; Base Sequence; Deoxyribonuclease HpaII; DNA, Neoplasm; Dosage Compensation, Genetic; Exons; Female; Fibroma; Humans; Kidney Neoplasms; Methylation; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Androgen; Trinucleotide Repeats; Tuberous Sclerosis; X Chromosome

1996